• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过表达NTRK1的人外周血间充质干细胞增强帕金森病大鼠模型的修复能力。

Human peripheral blood-derived mesenchymal stem cells with NTRK1 over-expression enhance repairing capability in a rat model of Parkinson's disease.

作者信息

Liu Kun, Zhang Wei, Li Yunlong, Ding Qingfeng, Bai Yunan, Wang Fachen, Xu Guangming

机构信息

Shandong Provincial Hospital Affiliated to Shandong University, No. 324 Jingwuweiqi Road, Jinan, 250021, Shandong Province, China.

Weifang Yidu Central Hospital, No. 4138 Linglongshan Road, Qingzhoushi, 262500, Shandong Province, China.

出版信息

Cytotechnology. 2018 Oct;70(5):1291-1299. doi: 10.1007/s10616-017-0175-3. Epub 2018 Jul 5.

DOI:10.1007/s10616-017-0175-3
PMID:29978273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6214848/
Abstract

The potency of mesenchymal stem cells (MSCs) for tissue repair and regeneration is mainly based on their ability to secret beneficial molecules. Administration of MSCs has been proposed as an innovative approach and is proved by a number of clinical trials to a certain degree for the therapy of many diseases including Parkinson's disease (PD). However, the efficacy of MSCs alone is not significant. We investigated the effect of neurotrophic tyrosine receptor kinase 1 (NTRK1) overexpressed peripheral blood MSCs (PB-MSCs) on PD rat model. NTRK1 was overexpressed in PB-MSCs, which were then injected into PD rat model, Dopaminergic (DA) neuron regeneration and rotational performance was assessed. We found that DA neuron repair was increased in lesion site, rotational performance was also improved in MSC transplanted PD rat, with most potent effect in NTRK1 overexpressed PB-MSC transplanted PD rat. Our results indicate that overexpression of NTRK1 in MSCs could be an optimized therapeutic way via MSCs for PD treatment.

摘要

间充质干细胞(MSCs)用于组织修复和再生的潜能主要基于其分泌有益分子的能力。MSCs的给药已被提议作为一种创新方法,并且在一定程度上已被多项临床试验证明可用于治疗包括帕金森病(PD)在内的多种疾病。然而,单独使用MSCs的疗效并不显著。我们研究了过表达神经营养性酪氨酸受体激酶1(NTRK1)的外周血间充质干细胞(PB-MSCs)对PD大鼠模型的影响。NTRK1在PB-MSCs中过表达,然后将其注射到PD大鼠模型中,评估多巴胺能(DA)神经元再生和旋转行为。我们发现,在损伤部位DA神经元修复增加,在移植了MSCs的PD大鼠中旋转行为也得到改善,在移植了过表达NTRK1的PB-MSCs的PD大鼠中效果最为显著。我们的结果表明,在MSCs中过表达NTRK1可能是一种通过MSCs优化治疗PD的方法。

相似文献

1
Human peripheral blood-derived mesenchymal stem cells with NTRK1 over-expression enhance repairing capability in a rat model of Parkinson's disease.过表达NTRK1的人外周血间充质干细胞增强帕金森病大鼠模型的修复能力。
Cytotechnology. 2018 Oct;70(5):1291-1299. doi: 10.1007/s10616-017-0175-3. Epub 2018 Jul 5.
2
GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.分泌胶质细胞源性神经营养因子的间充质干细胞在炎症驱动的帕金森病大鼠模型中提供局部神经保护作用。
Neuroscience. 2015 Sep 10;303:402-11. doi: 10.1016/j.neuroscience.2015.07.014. Epub 2015 Jul 10.
3
Human olfactory stem cells: As a promising source of dopaminergic neuron-like cells for treatment of Parkinson's disease.人类嗅觉干细胞:作为治疗帕金森病的多巴胺能神经元样细胞的一个有前景的来源。
Neurosci Lett. 2019 Mar 23;696:52-59. doi: 10.1016/j.neulet.2018.12.011. Epub 2018 Dec 12.
4
Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease.帕金森病大鼠模型中黑质内移植间充质干细胞的治疗效果。
J Neurosci Res. 2017 Mar;95(3):907-917. doi: 10.1002/jnr.23879. Epub 2016 Sep 12.
5
Conditioned medium from human amniotic epithelial cells may induce the differentiation of human umbilical cord blood mesenchymal stem cells into dopaminergic neuron-like cells.人羊膜上皮细胞条件培养液可诱导人脐带血间充质干细胞向多巴胺能神经元样细胞分化。
J Neurosci Res. 2013 Jul;91(7):978-86. doi: 10.1002/jnr.23225. Epub 2013 Apr 30.
6
Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson's disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons.热休克蛋白60对移植人脐带间充质干细胞源性多巴胺能样神经元的帕金森病大鼠模型行为改善的影响。
Neurochem Res. 2016 Jun;41(6):1238-49. doi: 10.1007/s11064-015-1816-6. Epub 2016 Jan 12.
7
Dextran-coated iron oxide nanoparticle-improved therapeutic effects of human mesenchymal stem cells in a mouse model of Parkinson's disease.葡聚糖包覆的氧化铁纳米颗粒增强人骨髓间充质干细胞在帕金森病小鼠模型中的治疗效果。
Nanoscale. 2018 Feb 8;10(6):2998-3007. doi: 10.1039/c7nr06976f.
8
LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.溶血磷脂酸(LPA)信号传导对于多巴胺能神经元的发育是必需的,并且在帕金森病的6-羟基多巴胺(6-OHDA)损伤模型中,通过LPA1受体的低表达而降低。
Neurol Sci. 2015 Nov;36(11):2027-33. doi: 10.1007/s10072-015-2295-x. Epub 2015 Jul 14.
9
Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.人骨髓间充质干细胞分泌组对帕金森病大鼠模型脑结构和动物行为的影响。
Stem Cells Transl Med. 2017 Feb;6(2):634-646. doi: 10.5966/sctm.2016-0071. Epub 2016 Sep 22.
10
Adenovirus vector-mediated ex vivo gene transfer of brain-derived neurotrophic factor (BDNF) tohuman umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) promotescrush-injured rat sciatic nerve regeneration.腺病毒载体介导的脑源性神经营养因子(BDNF)体外基因转移至人脐带血间充质干细胞(UCB-MSCs)可促进挤压损伤的大鼠坐骨神经再生。
Neurosci Lett. 2017 Mar 16;643:111-120. doi: 10.1016/j.neulet.2017.02.030. Epub 2017 Feb 13.

引用本文的文献

1
Combining xQTL and genome-wide association studies from ethnically diverse populations improves druggable gene discovery.将来自不同种族人群的全基因组关联研究与全基因组转录定量位点分析相结合,可改善可成药基因的发现。
Res Sq. 2025 May 28:rs.3.rs-6700169. doi: 10.21203/rs.3.rs-6700169/v1.
2
Induced pluripotent stem cell-related approaches to generate dopaminergic neurons for Parkinson's disease.用于帕金森病的诱导多能干细胞相关方法来生成多巴胺能神经元。
Neural Regen Res. 2025 Nov 1;20(11):3193-3206. doi: 10.4103/NRR.NRR-D-24-00771. Epub 2024 Dec 7.
3
Coumarin-chalcone hybrid LM-021 and indole derivative NC009-1 targeting inflammation and oxidative stress to protect BE(2)-M17 cells against α-synuclein toxicity.香豆素-查尔酮杂合体 LM-021 和吲哚衍生物 NC009-1 靶向炎症和氧化应激,以保护 BE(2)-M17 细胞免受α-突触核蛋白毒性的影响。
Aging (Albany NY). 2023 Aug 11;15(16):8061-8089. doi: 10.18632/aging.204954.
4
MSC based gene delivery methods and strategies improve the therapeutic efficacy of neurological diseases.基于间充质干细胞的基因递送方法和策略提高了神经疾病的治疗效果。
Bioact Mater. 2022 Nov 30;23:409-437. doi: 10.1016/j.bioactmat.2022.11.007. eCollection 2023 May.
5
β-Catenin promotes long-term survival and angiogenesis of peripheral blood mesenchymal stem cells via the Oct4 signaling pathway.β-连环蛋白通过 Oct4 信号通路促进外周血间充质干细胞的长期存活和血管生成。
Exp Mol Med. 2022 Sep;54(9):1434-1449. doi: 10.1038/s12276-022-00839-4. Epub 2022 Sep 1.
6
Molecular Regulatory Mechanism and Toxicology of Neurodegenerative Processes in MPTP/Probenecid-Induced Progressive Parkinson's Disease Mice Model Revealed by Transcriptome.通过转录组揭示 MPTP/丙磺舒诱导进行性帕金森病小鼠模型中神经退行性过程的分子调控机制和毒理学
Mol Neurobiol. 2021 Feb;58(2):603-616. doi: 10.1007/s12035-020-02128-5. Epub 2020 Sep 30.
7
Clinical Application Status of Articular Cartilage Regeneration Techniques: Tissue-Engineered Cartilage Brings New Hope.关节软骨再生技术的临床应用现状:组织工程软骨带来新希望。
Stem Cells Int. 2020 Jun 30;2020:5690252. doi: 10.1155/2020/5690252. eCollection 2020.

本文引用的文献

1
Mesenchymal stem cell therapy in Parkinson's disease animal models.帕金森病动物模型中的间充质干细胞疗法。
Curr Res Transl Med. 2017 Apr-Jun;65(2):51-60. doi: 10.1016/j.retram.2016.10.007. Epub 2016 Dec 2.
2
Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair.间充质干细胞衍生的细胞外囊泡用于肾脏修复
Curr Gene Ther. 2017;17(1):29-42. doi: 10.2174/1566523217666170412110724.
3
Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.人骨髓间充质干细胞分泌组对帕金森病大鼠模型脑结构和动物行为的影响。
Stem Cells Transl Med. 2017 Feb;6(2):634-646. doi: 10.5966/sctm.2016-0071. Epub 2016 Sep 22.
4
Intraarticular and intravenous administration of Tc-HMPAO-labeled human mesenchymal stem cells (TC-AH-MSC): In vivo imaging and biodistribution.锝-六甲基丙烯胺肟标记的人间充质干细胞(TC-AH-MSC)的关节内和静脉内给药:体内成像与生物分布
Nucl Med Biol. 2017 Mar;46:36-42. doi: 10.1016/j.nucmedbio.2016.12.003. Epub 2016 Dec 9.
5
Overview of retinal differentiation potential of mesenchymal stem cells: A promising approach for retinal cell therapy.间充质干细胞的视网膜分化潜能概述:一种有前景的视网膜细胞治疗方法。
Ann Anat. 2017 Mar;210:52-63. doi: 10.1016/j.aanat.2016.11.010. Epub 2016 Dec 13.
6
Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis.基于间充质干细胞的动脉粥样硬化治疗进展与展望
Am J Transl Res. 2016 Oct 15;8(10):4017-4024. eCollection 2016.
7
Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence.基于间充质干细胞的肾脏疾病治疗:临床证据综述
Stem Cells Int. 2016;2016:4798639. doi: 10.1155/2016/4798639. Epub 2016 Sep 19.
8
Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease.帕金森病大鼠模型中黑质内移植间充质干细胞的治疗效果。
J Neurosci Res. 2017 Mar;95(3):907-917. doi: 10.1002/jnr.23879. Epub 2016 Sep 12.
9
Mesenchymal Stem Cell Secretome: A Potential Tool for the Prevention of Muscle Degenerative Changes Associated With Chronic Rotator Cuff Tears.间充质干细胞分泌组:预防与慢性肩袖撕裂相关的肌肉退行性改变的潜在工具。
Am J Sports Med. 2017 Jan;45(1):179-188. doi: 10.1177/0363546516657827. Epub 2016 Aug 8.
10
Immunomodulatory properties of mesenchymal stem cell in experimental arthritis in rat and mouse models: A systematic review.间充质干细胞在大鼠和小鼠实验性关节炎模型中的免疫调节特性:一项系统综述。
Semin Arthritis Rheum. 2016 Aug;46(1):1-19. doi: 10.1016/j.semarthrit.2016.02.008. Epub 2016 Mar 7.